Trading For This Specialty Pharma Company is up Following Second Quarter Results
11 August 2023 - 1:00AM
AllPennyStocks.com
This stock is almost a penny stock no longer, as shares moved
close to the $5 threshold following the firm’s quarterly
announcement. Leading pan-American (ex-US) specialty pharmaceutical
firm...
To read the full story on AllPennyStocks.com, click
here.
Knight Therapeutics (TSX:GUD)
Historical Stock Chart
From Feb 2025 to Mar 2025
Knight Therapeutics (TSX:GUD)
Historical Stock Chart
From Mar 2024 to Mar 2025